Stonebridge Financial Group (Pennsylvania)’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$328K Buy
+1,324
New +$285K 0.02% 217
2026
Q1
Sell
-71,346
Closed -$14.7M 266
2025
Q4
$14.7M Buy
+71,346
New +$14.3M 1.26% 23
2025
Q2
Sell
-76,802
Closed -$13.1M 462
2025
Q1
$13.1M Buy
+76,802
New +$13.3M 1.39% 18

Other funds holding FBT

Stonebridge Financial Group (Pennsylvania)'s FBT Position: Q2 2026 in Review

Stonebridge Financial Group (Pennsylvania) opened a new position in First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026: 1,324 shares worth $328K. The stake represents 0.02% of the portfolio and ranks #217 among its holdings. This is a return to the name: Stonebridge Financial Group (Pennsylvania) previously reported a position in FBT as recently as Q4 2025.

Stonebridge Financial Group (Pennsylvania) first reported a position in FBT in Q1 2025 and has held it in 3 quarters since. The position peaked at $14.7M in Q4 2025. 288 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Stonebridge Financial Group (Pennsylvania) held 1,324 shares of First Trust NYSE Arca Biotechnology Index Fund worth $328K as of Q2 2026.
  • First Trust NYSE Arca Biotechnology Index Fund was a new Stonebridge Financial Group (Pennsylvania) position in Q2 2026.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.02% of Stonebridge Financial Group (Pennsylvania)'s portfolio in Q2 2026, its #217 holding.
  • Stonebridge Financial Group (Pennsylvania) first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2025 and has held it in 3 quarters since.
  • Stonebridge Financial Group (Pennsylvania)'s First Trust NYSE Arca Biotechnology Index Fund position peaked at $14.7M in Q4 2025.
  • 288 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Stonebridge Financial Group (Pennsylvania)'s 13F filing for Q2 2026, filed 6 Jul 2026.